Zacks Research Has Negative Estimate for Neogen Q1 Earnings

Neogen Corporation (NASDAQ:NEOG) – Zacks Research lowered their Q1 2026 earnings estimates for shares of Neogen in a research note issued on Wednesday, September 3rd. Zacks Research analyst Team now anticipates that the company will post earnings of $0.03 per share for the quarter, down from their prior forecast of $0.05. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share. Zacks Research also issued estimates for Neogen’s Q2 2026 earnings at $0.07 EPS, FY2026 earnings at $0.27 EPS, Q2 2027 earnings at $0.08 EPS, Q4 2027 earnings at $0.08 EPS and Q1 2028 earnings at $0.07 EPS.

Several other research analysts have also issued reports on NEOG. William Blair lowered shares of Neogen from an “outperform” rating to a “market perform” rating in a research report on Tuesday, July 29th. Guggenheim cut their price target on shares of Neogen from $13.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, June 30th. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $7.50.

Neogen Stock Up 0.2%

Shares of NASDAQ:NEOG opened at $5.75 on Thursday. Neogen has a 52-week low of $3.87 and a 52-week high of $17.95. The firm has a fifty day moving average of $5.25 and a 200 day moving average of $6.32. The firm has a market capitalization of $1.25 billion, a PE ratio of -1.14 and a beta of 1.85. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.22 and a current ratio of 3.32.

Institutional Trading of Neogen

A number of institutional investors have recently modified their holdings of NEOG. Gates Capital Management Inc. purchased a new stake in shares of Neogen during the first quarter worth about $79,391,000. Norges Bank purchased a new stake in shares of Neogen during the second quarter worth about $43,387,000. Clarkston Capital Partners LLC boosted its holdings in shares of Neogen by 123.2% during the second quarter. Clarkston Capital Partners LLC now owns 14,005,725 shares of the company’s stock worth $66,947,000 after purchasing an additional 7,729,650 shares during the period. Millennium Management LLC purchased a new stake in shares of Neogen during the first quarter worth about $20,761,000. Finally, Ameriprise Financial Inc. boosted its holdings in shares of Neogen by 169.5% during the second quarter. Ameriprise Financial Inc. now owns 3,079,123 shares of the company’s stock worth $14,718,000 after purchasing an additional 1,936,569 shares during the period. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.